The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?
Authors
Keywords
-
Journal
Pharmaceutics
Volume 11, Issue 3, Pages 99
Publisher
MDPI AG
Online
2019-02-27
DOI
10.3390/pharmaceutics11030099
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pickering emulsion stabilized by cashew gum- poly- l -lactide copolymer nanoparticles: Synthesis, characterization and amphotericin B encapsulation
- (2018) A.R. Richter et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Preparation of Amphotericin B-Ergosterol structures and molecular simulation of water adsorption and diffusion
- (2018) Hao-Chen Wu et al. JOURNAL OF MEMBRANE SCIENCE
- Revising Leishmania’s life cycle
- (2018) Paul A. Bates Nature Microbiology
- Mechanism of Binding of Antifungal Antibiotic Amphotericin B to Lipid Membranes: An Insight from Combined Single-Membrane Imaging, Microspectroscopy, and Molecular Dynamics
- (2018) Ewa Grela et al. MOLECULAR PHARMACEUTICS
- Mucoadhesive chitosan-coated nanostructured lipid carriers for oral delivery of amphotericin B
- (2018) Janet Sui Ling Tan et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- ROS formation is a differential contributory factor to the fungicidal action of Amphotericin B and Micafungin in Candida albicans
- (2017) José P. Guirao-Abad et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Unmet clinical needs in the treatment of systemic fungal infections: The role of amphotericin B and drug targeting
- (2017) Raquel Fernández-García et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Oral amphotericin B: The journey from bench to market
- (2017) Dolores R. Serrano et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- The care and feeding of a commercial liposomal product: liposomal amphotericin B (AmBisome®)
- (2017) Gerard M. Jensen JOURNAL OF LIPOSOME RESEARCH
- The direct costs of treating human visceral leishmaniasis in Brazil
- (2017) Tália Santana Machado de Assis et al. Revista da Sociedade Brasileira de Medicina Tropical
- Antifungal activity of oral (Tragacanth/acrylic acid) Amphotericin B carrier for systemic candidiasis: in vitro and in vivo study
- (2017) Heba A. Mohamed et al. Drug Delivery and Translational Research
- Liposomal Amphotericin B (AmBisome®): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions
- (2016) Neil R. H. Stone et al. DRUGS
- Naegleria fowleri: Pathogenesis, Diagnosis, and Treatment Options
- (2015) Eddie Grace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Physical characterization and in vivo pharmacokinetic study of self-assembling amphotericin B-loaded lecithin-based mixed polymeric micelles
- (2015) Ming-Thau Sheu et al. International Journal of Nanomedicine
- Oral Particle Uptake and Organ Targeting Drives the Activity of Amphotericin B Nanoparticles
- (2015) Dolores R. Serrano et al. MOLECULAR PHARMACEUTICS
- Solid lipid nanoparticles of amphotericin B (AmbiOnp): in vitro and in vivo assessment towards safe and effective oral treatment module
- (2015) Manisha B. Chaudhari et al. Drug Delivery and Translational Research
- The Production of Reactive Oxygen Species Is a Universal Action Mechanism of Amphotericin B against Pathogenic Yeasts and Contributes to the Fungicidal Effect of This Drug
- (2014) Ana Cecilia Mesa-Arango et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Study the effects of PLGA-PEG encapsulated Amphotericin B nanoparticle drug delivery system against Leishmania donovani
- (2014) Rishikesh Kumar et al. DRUG DELIVERY
- Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments
- (2014) Daniel Michał Kamiński EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
- An update on pharmacotherapy for leishmaniasis
- (2014) Shyam Sundar et al. EXPERT OPINION ON PHARMACOTHERAPY
- Amphotericin forms an extramembranous and fungicidal sterol sponge
- (2014) Thomas M Anderson et al. Nature Chemical Biology
- Significance of Algal Polymer in Designing Amphotericin B Nanoparticles
- (2014) Saurabh Bhatia et al. TheScientificWorldJOURNAL
- Efficacy and Safety of Amphotericin B Emulsion versus Liposomal Formulation in Indian Patients with Visceral Leishmaniasis: A Randomized, Open-Label Study
- (2014) Shyam Sundar et al. PLoS Neglected Tropical Diseases
- Mechanisms of cellular invasion by intracellular parasites
- (2013) Dawn M. Walker et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Spray dried chitosan–EDTA superior microparticles as solid substrate for the oral delivery of amphotericin B
- (2013) Kuldeep Singh et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Development of oil-in-water microemulsions for the oral delivery of amphotericin B
- (2013) Acarília Eduardo Silva et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Strategies for the design of orally bioavailable antileishmanial treatments
- (2013) T.T.H. Pham et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- New strategy for enhancing the therapeutic index of Fungizone ®
- (2013) L. Belkherroubi-Sari et al. JOURNAL DE MYCOLOGIE MEDICALE
- Efficacy of an oral and tropically stable lipid-based formulation of Amphotericin B (iCo-010) in an experimental mouse model of systemic candidiasis
- (2013) Fady Ibrahim et al. Lipids in Health and Disease
- Development of Amphotericin B-Loaded Cubosomes Through the SolEmuls Technology for Enhancing the Oral Bioavailability
- (2012) Zhiwen Yang et al. AAPS PHARMSCITECH
- Phlebotomine sandflies and the spreading of leishmaniases and other diseases of public health concern
- (2012) M. MAROLI et al. MEDICAL AND VETERINARY ENTOMOLOGY
- Leishmaniasis Worldwide and Global Estimates of Its Incidence
- (2012) Jorge Alvar et al. PLoS One
- Amphotericin primarily kills yeast by simply binding ergosterol
- (2012) K. C. Gray et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug
- (2012) Ana C. Mesa-Arango et al. Frontiers in Microbiology
- Leishmania-host interactions: what has imaging taught us?
- (2011) Lynette Beattie et al. CELLULAR MICROBIOLOGY
- Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes
- (2011) V. K. Prajapati et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- An Oral Formulation of Amphotericin B Attached to Functionalized Carbon Nanotubes Is an Effective Treatment for Experimental Visceral Leishmaniasis
- (2011) Vijay Kumar Prajapati et al. JOURNAL OF INFECTIOUS DISEASES
- Tropically stable novel oral lipid formulation of amphotericin B (iCo-010): biodistribution and toxicity in a mouse model
- (2011) Olena Sivak et al. Lipids in Health and Disease
- Synthesis-enabled functional group deletions reveal key underpinnings of amphotericin B ion channel and antifungal activities
- (2011) D. S. Palacios et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Barriers to treatment for visceral leishmaniasis in hyperendemic areas: India, Bangladesh, Nepal, Brazil and Sudan
- (2010) Sheila J. Thornton et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Amphotericin B Lipid Complex (Abelcet®) in the treatment of invasive mycoses: the North American experience
- (2010) J. Lister EUROPEAN JOURNAL OF HAEMATOLOGY
- A Novel Tropically Stable Oral Amphotericin B Formulation (iCo-010) Exhibits Efficacy against Visceral Leishmaniasis in a Murine Model
- (2010) Ellen K. Wasan et al. PLoS Neglected Tropical Diseases
- The reformulation of Amphotericin B for oral administration to treat systemic fungal infections and visceral leishmaniasis
- (2009) Sheila J Thornton et al. Expert Opinion on Drug Delivery
- Development and characterization of oral lipid-based Amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans
- (2009) Ellen K. Wasan et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Highly Effective Oral Amphotericin B Formulation against Murine Visceral Leishmaniasis
- (2009) Kishor M. Wasan et al. JOURNAL OF INFECTIOUS DISEASES
- Effect of aggregation state on the toxicity of different amphotericin B preparations
- (2008) Raquel Espada et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started